Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...

Novo Nordisk has reported that its 2.4mg dosage of semaglutide (Wegovy) demonstrated a reduction in liver injury ...

AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

Newark, NJ - - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been awarded a 2025 Silver Anthem Award for ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

Scientists at the University of Edinburgh have identified new drug targets within bacterial cells that could help overcome ...

The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient ...

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role ...

Merck (known as MSD outside the US and Canada) has entered into a funding agreement with Blackstone Life Sciences to support ...

Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...